HeartBeam has secured two new US patents, strengthening its intellectual property (IP) portfolio in cardiac monitoring ...

BrightHeart has gained a further 510(k) clearance from the FDA for its AI-based prenatal congenital heart defect (CHD) ...

Health Canada has approved Merit Medical Systems’ Wrapsody cell-impermeable endoprosthesis (CIE) device for haemodialysis ...

Roche has introduced the Elecsys PRO-C3 test for evaluating the liver fibrosis severity in individuals with signs of MASLD.

The Final Rule was mooted for implementation over a staged transition period, determined by a service’s risk level, by 2028.

URA has entered the consumer diabetes space, offering a new glucose feature for its ring that uses insights from Dexcom’s CGM ...